Skip to main content

Table 1 Baseline characteristics of study patients at time of ICD implant

From: Myocardial strain assessment using cardiovascular magnetic resonance imaging in recipients of implantable cardioverter defibrillators

N

364

Mean age, years (SD)

60.9 (13.5)

Male (%)

78.6

Hypertension (%)

51.4

Diabetes (%)

28.9

Dyslipidemia (%)

48.9

Current smoking (%)

11.8

Prior angina (%)

14.3

Prior myocardial infarction (%)

41.2

Prior stroke (%)

8.0

Prior heart failure (%)

39.6

Prior cardiac arrest (%)

11.6

Prior PCI (%)

21.2

Prior CABG (%)

16.5

Chronic kidney disease (%)

4.9

Primary prevention indication (%)

61.0

Ischemic heart disease (%)

57.4

Dilated cardiomyopathy (%)

25.0

Hypertrophic cardiomyopathy (%)

3.8

Myocarditis (%)

3.3

Sarcoidosis (%)

3.0

Other cardiomyopathy (%)

9.6

Cardiovascular medications (%)

   Aspirin

55.7

   Anticoagulant

27.8

   ADP receptor inhibitor

15.9

   Diuretic

44.0

   Beta-blocker

82.3

   ACEi

64.4

   ARB

11.4

   Statin

64.9

 Antiarrhythmic

16.2

   Amiodarone

12.8

   Other

3.4

CMR parameters, mean (SD)

   LVEDVI, mL/m2

140.0 (45.4)

   LVESVI, mL/m2

99.3 (45.4)

   LVMI, g/m2

70.6 (19.0)

   LVEF, %

32.1 (13.8)

   GLS, %

− 9.0 (4.3)

   GCS, %

− 9.9 (5.0)

   GRS, %

19.9 (12.0)

  1. ACEi angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, CMR cardiovascular magnetic resonance, LVEF left ventricular ejection fraction, LVESVI left ventricular end-systolic volume index, LVEDVI left ventricular end-diastolic volume index, LVMI left ventricular mass index, GLS global longitudinal strain, GCS global circumferential strain, GRS global radial strain, PCI percutaneous coronary intervention, CABG coronary artery bypass graft surgery, SD standard deviation